16 results
P
NSCLC patients
I/C
Xiao-ai-ping injection (XAPI) + platinum-based chemotherapy, platinum-based chemotherapy alone
O
objective tumor response rate (ORR), Karnofsky performance scores (KPS), occurrence of grade 3/4 leukopenia, anemia, thrombocytopenia, nausea and vomiting, immune function (CD8)
P
Hu ML, Zheng G, Lin H, Yang M, Zhang YD, Han JM
I/C
Desensitizing Toothpastes
O
Dentine Hypersensitivity
P
patients with carious lesions
I/C
stepwise removal technique, complete removal technique
O
pulp exposure, signs and symptoms of pulp disease, restoration failure
P
lung/gastric/liver cancer patients, controls
I/C
meta-analysis, previous related studies, present study
O
association with cancer susceptibility
P
adult population, over 60 years old, under 18 years old
I/C
reminder sent by mail
O
adherence to influenza vaccination
P
792 patients
I/C
literature search using Pubmed, Scopus/EMBASE, and the Cochrane Library databases, seven studies (n=792) in the meta-analysis
O
mean and 95th percentile of the incubation period
P
patients undergoing orthognathic surgery
I/C
long-term antibiotic prophylaxis, short-term antibiotic prophylaxis
O
surgical site infection, hospital stay longer than two days
P
patients with polypoidal choroidal vasculopathy
I/C
anti-vascular endothelial growth factor drugs, photodynamic therapy, combination of photodynamic therapy and anti-vascular endothelial growth factor drugs, anti-vascular endothelial growth factor drugs alone
O
incidence of retinal hemorrhage, visual acuity gain, polyp regression, central retinal thickness
P
COVID-19 patients
I/C
3-drugs-3-formulas, conventional treatment
O
duration of fever, cough, fatigue, length of hospital stay, time for nucleic acid conversion, aggravation rate, mortality, recovery rate of chest computerized tomography manifestations, total effectiveness
P
people being investigated for tuberculosis
I/C
Xpert MTB/RIF, smear microscopy
O
mortality, proportion of participants starting tuberculosis treatment who had a successful treatment outcome, proportion of participants who were treated for tuberculosis, proportion of participants with bacteriological confirmation who were lost to follow-up pre-treatment, proportion of treated participants who had bacteriological confirmation